» Articles » PMID: 22440044

Clinical Implication of Urinary Tubular Markers in the Early Stage of Nephropathy with Type 2 Diabetic Patients

Overview
Specialty Endocrinology
Date 2012 Mar 24
PMID 22440044
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: The aim of this study was to evaluate the association of urinary tubular markers, interleukin-18 (IL-18) and angiotensinogen with albuminuria in early nephropathy of type 2 diabetics.

Methods: Urine levels of tubular markers (kidney injury molecule [KIM]-1, neutrophil gelatinase-associated lipocalin [NGAL] and liver-type fatty acid-binding protein [L-FABP]), proinflammatory marker (IL-18), and a marker of intrarenal renin-angiotensin system (RAS) status (angiotensinogen) were determined in 118 patients with type 2 diabetes mellitus and 25 non-diabetic controls with estimated glomerular filtration rate (eGFR) ≥ 60 mL/min/1.73 m(2).

Results: Urinary levels of KIM-1, NGAL, IL-18 and angiotensinogen were significantly higher in macroalbuminuria group compared with control and normo- and microalbuminuria groups but not significantly different between control and normoalbuminuria group. Urinary tubular markers were positively correlated with urinary IL-18 and angiotensinogen, respectively. The urinary albuminuria was correlated with all investigated urinary markers in univariate analysis. After adjusting for several clinical parameters, urinary KIM-1, NGAL and angiotensinogen were significantly associated with albuminuria.

Conclusions: The results of this study suggest that urinary tubular markers may be independently associated with albuminuria in the early stage of nephropathy in type 2 diabetics (eGFR ≥ 60 mL/min/1.73 m(2)) and may reflect inflammatory processing and the activation of the intrarenal RAS.

Citing Articles

Changes in Urinary NGAL, FN, and LN Excretion in Type 2 Diabetic Patients Following Anti-Diabetic Therapy with Metformin.

Szeremeta A, Jura-Poltorak A, Grim A, Kuznik-Trocha K, Olczyk P, Ivanova D J Clin Med. 2025; 14(4).

PMID: 40004620 PMC: 11856773. DOI: 10.3390/jcm14041088.


Neutrophil gelatinase-associated lipocalin, kidney injury molecule-1, and periostin: Novel urinary biomarkers in diabetic nephropathy.

Varatharajan S, Jain V, Pyati A, Neeradi C, Sugunakar Reddy K, Pallavali J World J Nephrol. 2024; 13(4):98880.

PMID: 39723350 PMC: 11572651. DOI: 10.5527/wjn.v13.i4.98880.


Simultaneous detection of multiple urinary biomarkers in patients with early-stage diabetic kidney disease using Luminex liquid suspension chip technology.

Li X, Zhang X, Wang S, Li Y, Meng C, Wang J Front Endocrinol (Lausanne). 2024; 15:1443573.

PMID: 39229378 PMC: 11369644. DOI: 10.3389/fendo.2024.1443573.


Lipocalin-2, Soluble Transferrin Receptor, and Erythropoietin in Anemia During Mild Renal Dysfunction.

Nahm C, Lee M, Fujii T, Fujii N, Choi J Int J Gen Med. 2023; 16:3603-3612.

PMID: 37637706 PMC: 10455969. DOI: 10.2147/IJGM.S422411.


Significance of Diabetic Kidney Disease Biomarkers in Predicting Metabolic-Associated Fatty Liver Disease.

Bae J, Lee B Biomedicines. 2023; 11(7).

PMID: 37509567 PMC: 10377561. DOI: 10.3390/biomedicines11071928.